Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Effects of Dietary Intervention on Gastrointestinal Function in Patients With Anorexia Nervosa and Obesity

This study has been completed.
Sponsor:
Collaborator:
Schweizerischer Nationalfonds
Information provided by (Responsible Party):
University of Zurich
ClinicalTrials.gov Identifier:
NCT00946816
First received: July 20, 2009
Last updated: November 13, 2012
Last verified: November 2012

July 20, 2009
November 13, 2012
September 2010
November 2012   (final data collection date for primary outcome measure)
The GI response to a given meal in terms of: motility, neurohormonal feedback, sensation and satiety [ Time Frame: 2 years ] [ Designated as safety issue: No ]
The GI response to a given meal in terms of: motility, neurohormonal feedback, sensation and satiety
Complete list of historical versions of study NCT00946816 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The Effects of Dietary Intervention on Gastrointestinal Function in Patients With Anorexia Nervosa and Obesity
The Effects of Dietary Intervention on Gastrointestinal Motility, Hormonal Feedback, Visceral Sensation and Satiety in Patients With Anorexia Nervosa and Obesity

Diseases characterized by abnormal low and high body weight are common in the community and are associated with significant morbidity, mortality and health care related costs.

Genetic, dietary, social and psychologic factors all play an important part in these conditions; however the central role of gastrointestinal (GI) function and the control of nutrient delivery to the small bowel has not been well described in health or disease.

We propose that the GI response to feeding varies inversely with body weight. This hypothesis predicts that as body weight increases, the response to a given meal decreases in terms of motility, neurohormonal feedback, sensation and satiety. This provides an attractive explanation for why thin individuals stop eating after a small amount of food (i.e. limited gastric relaxation, rapid gastric emptying, powerful nutrient feedback with early satiety)and, conversely, why obese patients continue to eat even after nutritional requirements have been met (i.e. large gastric relaxation, slow gastric emptying, weak nutrient feedback with delayed satiety).

This project will apply MRI and Breath Tests to assess GI motility, hormonal feedback, visceral sensation and satiety in patients with pathologically low (anorexia nervosa) and high (morbid obesity) body weight and in healthy, normal weight controls.

Participants will include: Group A: normal weight, healthy volunteers (n=24: BMI: 18.5-24.9 kg/m2) Group B: patients with anorexia nervosa (DSMIV criteria and BMI: <16 kg/m2) B1: anorexia restricting type (n=12-20 over 2 years) and B2: anorexia bulimia type (n=20 over 2 years) Group C: patients with morbid obesity (BMI: 30-40 kg/m2) C1: obese (n=20 over 2 years) and C2: obese with DM type II (n=20 over 2 years).

Two studies will be performed

  1. Cross-sectional study: The effects of a test meal on GI motility, hormonal feedback, visceral sensation and satiety in healthy controls and in patients with anorexia and obesity
  2. Longitudinal study: The effects of dietary treatment (i.e. weight change) on GI motility, hormonal feedback, visceral sensation and satiety in patients with anorexia and obesity
Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Anorexia Nervosa
  • Obesity
  • Healthy Participants
Behavioral: Nutritional Intervention
Nutritional Intervention
  • Active Comparator: Anorexia Nervosa
    Intervention: Behavioral: Nutritional Intervention
  • Active Comparator: Obesity
    Intervention: Behavioral: Nutritional Intervention
  • Active Comparator: Healthy volunteers
    Intervention: Behavioral: Nutritional Intervention
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
60
November 2012
November 2012   (final data collection date for primary outcome measure)

In addition to satisfying specific DSMIV criteria for anorexia nervosa (B1, B2) or WHO criteria for obesity (C1), or obesity and diabetes mellitus type II (C2), general inclusion criteria include:

  • aged at least 18 and not more than 40 years
  • able to communicate well with the investigators and provide written consent
  • no physical co-morbidity requiring active treatment, in particular diabetes mellitus, impairment of liver or kidney function (subjects with diabetes mellitus type II are eligible for study group C2)
  • no psychiatric (DSM IV) disorders limiting the ability to comply with study requirements
  • no use of medications influencing upper GI motility within one week of the study (i.e. nitrates, prokinetic drugs, macrolide antibiotics). Acid suppression and antihypertensive medication beta-blocker, calcium channel blockers are acceptable.
  • no evidence of current drug or alcohol abuse
  • no history of gastrointestinal disease or surgery except appendicectomy or hernia repair
  • females will take a urine pregnancy test before each study, any participant with a positive pregnancy test will be excluded (females will be investigated always in the same menstrual phase)

Exclusion criteria:

• pregnancy

Both
18 Years to 40 Years
No
Contact information is only displayed when the study is recruiting subjects
Switzerland
 
NCT00946816
SNF 320030_1253331
Not Provided
University of Zurich
University of Zurich
Schweizerischer Nationalfonds
Principal Investigator: Michael Fried, Professor MD University Hospital Zurich, Gastroenterology and Hepatology
University of Zurich
November 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP